查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654161

急性復发性癫痫市场规模、份额、趋势分析报告：产品、地区、细分市场预测，2025-2030 年

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

急性復发性癫痫市场的成长与趋势

根据 Grand View Research, Inc. 的最新报告，全球急性復发性癫痫市场规模预计到 2030 年将达到 64.8 亿美元，2025 年至 2030 年的复合年增长率为 12.7%。

不断提高人们对癫痫的认识是推动市场发展的主要因素。

目前市场由学名药驱动，主要含有口服苯二氮平类药物（Diazepam和Lorazepam）。唯一核准使用的药物是美国的直肠地西Diazepam和欧盟的颊部咪达唑仑。其他药物，如Diazepam（口服和肌肉注射）、咪达唑仑（颊内、鼻内、肌肉注射）、Lorazepam（口服、鼻内、舌下）和黄体酮，主要用于仿单标示外。市场由少数几家大公司主导，预计这些公司将占据较高的市场占有率。

此外，为了控制医疗支出，政府正在努力透过诊所和居家医疗等门诊护理模式来减少住院时间和现场护理费用。印度和中国等新兴经济体正在越来越多地实施此类医疗改革，预计将推动急性復发性癫痫市场的成长。

给药途径有多种，其中鼻腔途径比颊部、直肠和非肠道途径更受青睐。口腔给药较受儿童癫痫病患儿的看护者和家长的青睐，因为这种方式可以在医院外给药。

急性復发性癫痫市场报告重点

  • 预计 2024 年全球急性复发性癫痫市场规模为 31.5 亿美元，预测期内复合年增长率为 12.7%。
  • USL-261 占据市场主导地位，到 2024 年将占 44.5% 的份额。这是因为它作为一种鼻内治疗手段能够快速控制癫痫发作。
  • 北美急性復发性癫痫市场占据全球市场主导地位，2024 年的收入份额为 43.0%。该地区市场的成长得益于癫痫和神经系统疾病的高发性，以及强大的医疗保健基础设施。
  • 2024 年，日本急性反覆癫痫市场在亚太地区急性反覆癫痫市场占据主导地位。人口老化和对神经系统疾病认识的提高刺激了对有效治疗方法的需求。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章急性复发性癫痫市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析 – 波特五力分析
    • PESTLE分析

第 4 章急性复发性癫痫市场：产品业务分析

  • 2024 年及 2030 年产品市场占有率
  • 产品细分仪表板
  • 2018 年至 2030 年按产品分類的市场规模、预测与趋势分析
  • USL-261
  • NRL-1
  • AZ-002
  • Diastat 直肠凝胶
  • 其他的

第 5 章急性复发性癫痫市场：区域、估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018-2030
  • 北美洲
    • 依国家/地区，2018 年至 2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 依国家/地区，2018 年至 2030 年
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 依国家/地区，2018 年至 2030 年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 依国家/地区，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 依国家/地区，2018 年至 2030 年
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争格局

  • 参与者概述
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • UCB SA, Belgium
    • Neurelis, Inc.
    • Bausch Health Companies Inc.
    • Grupo Ferrer Internacional, SA
    • SERB
Product Code: GVR-2-68038-489-5

Acute Repetitive Seizures Market Growth & Trends:

The global acute repetitive seizures market size is estimated to reach USD 6.48 billion by 2030, expanding at a CAGR of 12.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Acute Repetitive Seizures Market Report Highlights:

  • Global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is expected to register a CAGR of 12.7% over the forecast period
  • USL-261 dominated the market and accounted for a share of 44.5% in 2024, owing to its effectiveness as an intranasal treatment aimed at achieving rapid seizure control.
  • North America acute repetitive seizures market dominated the global market with a revenue share of 43.0% in 2024. Market growth in the region is driven by a high prevalence of epilepsy and neurological disorders, complemented by a robust healthcare infrastructure.
  • The acute repetitive seizures market in Japan dominated the Asia Pacific acute repetitive seizures market in 2024. The aging population, coupled with rising awareness of neurological disorders, stimulates demand for effective therapies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Acute Repetitive Seizures Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Acute Repetitive Seizures Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. USL-261
    • 4.4.1. USL-261 Market, 2018 - 2030 (USD Million)
  • 4.5. NRL-1
    • 4.5.1. NRL-1 Market, 2018 - 2030 (USD Million)
  • 4.6. AZ-002
    • 4.6.1. AZ-002 Market, 2018 - 2030 (USD Million)
  • 4.7. Diastat Rectal Gel
    • 4.7.1. Diastat Rectal Gel Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Acute Repetitive Seizures Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. UCB S.A., Belgium
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Neurelis, Inc.
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. Bausch Health Companies Inc.
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Grupo Ferrer Internacional, S.A.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. SERB
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 5. North America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 7. U.S. acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 8. Canada acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 9. Mexico acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 10. Europe acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 11. Europe acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 12. UK acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 13. Germany acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 14. France acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 15. Italy acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 16. Spain acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 17. Norway acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 18. Denmark acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 19. Sweden acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 22. Japan acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 23. China acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 24. India acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 25. Australia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 26. South Korea acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 27. Thailand acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 28. Latin America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 29. Latin America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 30. Brazil acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 31. Argentina acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 34. South Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 36. UAE acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait acute repetitive seizures market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Acute repetitive seizures market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Acute repetitive seizures market dynamics
  • Fig. 12 Acute repetitive seizures market: Porter's five forces analysis
  • Fig. 13 Acute repetitive seizures market: PESTLE analysis
  • Fig. 14 Acute repetitive seizures market: Product segment dashboard
  • Fig. 15 Acute repetitive seizures market: Product market share analysis, 2024 & 2030
  • Fig. 16 USL-261 market, 2018 - 2030 (USD Million)
  • Fig. 17 NRL-1 market, 2018 - 2030 (USD Million)
  • Fig. 18 AZ-002 market, 2018 - 2030 (USD Million)
  • Fig. 19 Diastat rectal gel market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Acute repetitive seizures market revenue, by region
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. country dynamics
  • Fig. 26 U.S. acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada country dynamics
  • Fig. 28 Canada acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico country dynamics
  • Fig. 30 Mexico acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 32 UK country dynamics
  • Fig. 33 UK acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany country dynamics
  • Fig. 35 Germany acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway country dynamics
  • Fig. 43 Norway acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden country dynamics
  • Fig. 45 Sweden acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina country dynamics
  • Fig. 65 Argentina acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 66 MEA acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa country dynamics
  • Fig. 68 South Africa acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia country dynamics
  • Fig. 70 Saudi Arabia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE country dynamics
  • Fig. 72 UAE acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait country dynamics
  • Fig. 74 Kuwait acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 75 Company categorization
  • Fig. 76 Company market position analysis
  • Fig. 77 Strategic framework